MedPath

IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 10%

IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 10%

Discontinued
DIN Number

02230920

Drug Class

Human

Market Date

Jul 31, 2000

Company
HC

TALECRIS BIOTHERAPEUTICS INC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02230920
AIG Number0106267015
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BA02 IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASC. ADM.
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification80:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IMMUNOGLOBULIN (HUMAN)Active
Strength: 10 G / 100 ML
Monograph: IMMUNOGLOBULIN (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.